Reporting season is not know. As confession season for nothing for every 5 Coys that meet guidance or exceed it ten dont
It's the language in the report thats important things like unseasonal global prices over supply eye etc you see it all the time
How many stocks would we all but if you believed everything in the guidance it's open to so many macro factors at the half year did they know the chinese were going to apply an online sales tax did they know couriers stopped buying while the confusion reigned
Did they know the global milk glut was going to get worse an milk prices were going to deteriorate
Did they know other competitors wete going to bob up in the IF space a lot cab an does happen that's why guidance on any stock should never be taken as gospel
They have set the bar very high here I agree the EPS looks stunning on paper an Thats what drives the SP my burning question is where's the catch an I think it's going to come from the UK an US that's the part I feel may let people down on there expectations
I have little doubt they have made awesome money my doubt is Tho is it as much as what investors are hoping for on a PE this high analysts will look for any excuse to mark it down
So you better hope an pray they beat guidance by a long way if they don't Im
Afraid a lord major of Hiroshima moment awaits the expectant millionaires I see it all the time
The other thing is who here has jumped or sold some shares to buy the hot sectors still running that has had an affect
Bottom line is dead cat bounces are common it's what the stock does in the next few sessions
More importantly what are the numbers Im
Happy to wait to find out on the sidelines for now
- Forums
- ASX - By Stock
- A2M
- TA price target 1.06 A2M
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

TA price target 1.06 A2M, page-773
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online